drugset / Trial / NCT00258908
Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan
Non-randomizedSingle-groupOpen-labelPrevention
Summary
To assess the immunogenicity profile of ADACEL™, Tetanus and Diphtheria Toxoids Adsorbed combined with Component Pertussis Vaccine (TdcP Vaccine) one month after administration. To describe the safety profile of ADACEL™ (TdcP Vaccine) when given as a fifth dose.
Timeline
- Start
- 2005-11
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adacel | Vaccine | 0.5 ml | Intramuscular |